Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy

Determination of the risk-benefit ratio associated with the use of novel coronavirus disease 2019 (COVID-19) repurposed drugs in older adults with polypharmacy is mandatory. Our objective was to develop and validate a strategy to assess risk for adverse drug events (ADE) associated with COVID-19 rep...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical medicine 2020-08, Vol.9 (8), p.2591
Hauptverfasser:	Al Rihani, Sweilem B, Smith, Matt K, Bikmetov, Ravil, Deodhar, Malavika, Dow, Pamela, Turgeon, Jacques, Michaud, Veronique
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical medicine Coronaviruses COVID-19 Drug dosages Polypharmacy Prescription drugs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!